Table 5 Public Spending on 10 Selected Orphan Medicinal Products in 6 EU Countries in 2013–14
From: The European challenges of funding orphan medicinal products
Average spending per 100,000 inhabitants in 2013–14 | Ratio of spending compared to the average of 6 countries | |
|---|---|---|
Belgium | 281,878 € | 2,15 |
Bulgaria | 34,586 € | 0,26 |
Czech Republic | 115,187 € | 0,88 |
Hungary | 83,097 € | 0,63 |
Poland | 51,591 € | 0,39 |
Slovenia | 219,926 € | 1,68 |